Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. GSK plc.
  3. News

GSK plc.

  • Overview
  • Financial
  • In Reports
  • Products
  • History
  • Point of Contacts
  • News

In News

Japan’s Ministry of Health, Labour and Welfare accepts regulatory application to expand use of GSK’s RSV vaccine, Arexvy, in adults aged 18-49 at increased risk of severe RSV disease - GSK

GSK - Jun 20, 2025

GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold? - Yahoo Finance

Yahoo Finance - Jun 18, 2025

GSK's Specialty Medicines Surge—Still Looks Undervalued In 2025 - Seeking Alpha

Seeking Alpha - Jul 07, 2025

GSK: to present new data on HIV - MarketScreener

MarketScreener - Jul 09, 2025

GSK R&D expenditure 2024 - Statista

Statista - Jun 20, 2025

GSK's asthma drug wins FDA approval to treat 'smoker's lung' - Reuters

Reuters - May 23, 2025

GSK provides update on belrestotug development programme - GSK

GSK - May 13, 2025

GSK Licenses Shigella Vaccine to Bharat Biotech - Yahoo Finance

Yahoo Finance - Jun 16, 2025

GSK’s RSV vaccine, Arexvy, accepted for regulatory review by the European Medicines Agency to expand use in adults 18 years and older - GSK

GSK - Jun 13, 2025

GSK plc (GSK) Stock Rises as FDA Approves Nucala for COPD, CHMP Backs Blenrep for Cancer Treatment - Yahoo Finance

Yahoo Finance - May 24, 2025

GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline - GSK

GSK - Oct 29, 2024

Is GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? - Yahoo Finance

Yahoo Finance - May 13, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All